|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Original Article | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Volume 3, Number 1, February 2010, pages 19-24 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Clinical Research on the Relation Between Body Mass Index, Motilin and Slow Transit Constipation
aDepartment
of Gastroenterology, Sanming First Affiliated Hospital of Fujian Medical
University, Sanming 365000, China
Manuscript accepted for publication February 8, 2009
Abstract Background: Constipation is a common clinical symptom but its etiology remains unknown. The aims of the study are to discuss the relation between body mass index (BMI), motilin and the slow transit constipation (STC). Methods: A total of 178 patients with STC and 123 healthy volunteers as controls were divided into three groups according to the BMI, group A (BMI <20), group B (BMI 20-25), and group C (BMI > 25). Fasting and one hour postprandial plasma motilin were measured and the results were analyzed. Results: There was significant difference in the constituent ratio between STC patients and healthy controls (p < 0.05). The percentage of group A, B and C in STC patients was 49.4% (88/178), 23.0% (41/178) and 27.6% (49/178), respectively; and group A had a higher percentage. Plasma motilin of fasting and one hour postprandial in STC patients of group A was significantly lower than that of group B and C (p < 0.05), but there was no difference between group B and C (p > 0.05). There was no significant difference in the results of plasma motilin of fasting and one hour postprandial among the three groups of healthy controls (p > 0.05). Plasma motilin of fasting and one hour postprandial in STC patients of group A was significantly lower than those healthy controls of group A (p < 0.05). The same results of plasma motilin of fasting and one hour postprandial could be seen in group B and C, respectively (p < 0.05). Conclusions: A higher proportion of low BMI sufferers was found in the STC patients. The reason may be related to the lower release of the plasma motilin.
Introduction
Patients
A total of 123
healthy volunteers were recruited as controls. The volunteers were
recruited through advertisement. They were interviewed by
validated
questionnaires [1]
and the research
nurses about their health status. They did not have any past chronic
medical disease including gastrointestinal diseases.
No volunteer complained of abdominal pain, abdominal distention, or
disturbances in bowel habits. The average defecation frequency was 1 per
day. A careful drug history was obtained for each subject to ascertain
that none had taken drugs known to influence gastrointestinal motility
during the 2 weeks before the study. No volunteer had previously
undergone abdominal or pelvic surgery.
Assessment of
bowel transit time
Blood
sample handling and motilin assay Statistical analysis The results were analyzed statistically by analysis of variance, X2 and t tests. We used SPSS 11.5 software for statistical analysis. A p value of less than 0.05 was considered statistically significance throughout. Values are given as the mean + SD.
Discussion Conflict of Interest
None of the authors of this manuscript have any relevant financial
disclosures or conflicts of interest to state.
Specific author contributions
Hong Bin Chen, Yue Huang and Hui Wen Song initiated the study design.
Hong Bin Chen, Yue Huang, Jia Tai Xie, Chun Huang and Sheng Jun Zhang
performed all the studies. Xiao Lin Li, Hong Bin Chen, Yue Huang
performed the majority of the data analysis. Hong Bin Chen, Song Hui Wen
and Song He edited the manuscript draft. Acknowledgement
We wish to thank our
colleagues, technicians and nurses for their great help and cooperation
during performing this study. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| References | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1. | Fang XC. The treatment guideline of chronic constipation in china. Chinese Journal of Digestion.2007; 27(9):619-622. |
| 2. |
Higgins PD, Johanson JF. Epidemiology of constipation in North America:
a systematic review. Am J Gastroenterol 2004;99(4):750-759. [Medline] [CrossRef] |
| 3. |
Harrington KL, Haskvitz EM. Managing a patient's constipation with
physical therapy. Phys Ther 2006;86(11):1511-1519. [Medline] [CrossRef] |
| 4. |
Glia A,
Lindberg G. Quality of life in patients with different types of
functional constipation. Scand J Gastroenterol 1997;32(11):1083-1089.
[Medline] [CrossRef] |
| 5. |
Lembo A,
Camilleri M. Chronic constipation. N Engl J Med 2003;349(14):1360-1368.
[Medline] [CrossRef] |
| 6. |
Leifeld
L, Fink K, Debska G, Fielenbach M, Schmitz V, Sauerbruch T, Spengler U.
Anti-apoptotic function of gelsolin in fas antibody-induced liver
failure in vivo. Am J Pathol 2006;168(3):778-785. [Medline] [CrossRef] |
| 7. |
Watanabe
T, Nakaya N, Kurashima K, Kuriyama S, Tsubono Y, Tsuji I. Constipation,
laxative use and risk of colorectal cancer: The Miyagi Cohort Study. Eur
J Cancer 2004;40(14):2109-2115. [Medline] [CrossRef] |
| 8. | Drossman DA, Thompson WG, Talley NJ, Funch-Jenesn P, Jansens J, Whitehead WE. Rome II. multinational consensus document on functional gastrointestinal disorders. Gut. 1999; 45(Suppl 2): II1-1181. |
| 9. |
Chaussade
S, Khyari A, Roche H, Garret M, Gaudric M, Couturier D, Guerre J.
Determination of total and segmental colonic transit time in constipated
patients. Results in 91 patients with a new simplified method. Dig Dis
Sci 1989;34(8):1168-1172. [Medline] [CrossRef] |
| 10. |
Metcalf
AM, Phillips SF, Zinsmeister AR, MacCarty RL, Beart RW, Wolff BG.
Simplified assessment of segmental colonic transit. Gastroenterology
1987;92(1):40-47. [Medline] |
| 11. | Dnburgh JR, Broun JC. RIA motilin. Gastroenterology. 1975;68:1169. |
| 12. |
Jenssen
TG, Burhol PG, Jorde R, Florholmen J, Lygren I. Radioimmunoassayable
plasma motilin in man. Secretagogues, insulin-induced suppression, renal
removal, and plasma components. Scand J Gastroenterol
1984;19(6):717-723. [Medline] |
| 13. |
Talley
NJ. Definitions, epidemiology, and impact of chronic constipation. Rev
Gastroenterol Disord 2004;4 Suppl 2(S3-S10. [Medline] |
| 14. |
Heaton
KW, Cripps HA. Straining at stool and laxative taking in an English
population. Dig Dis Sci 1993;38(6):1004-1008. [Medline] [CrossRef] |
| 15. |
Stewart
WF, Liberman JN, Sandler RS, Woods MS, Stemhagen A, Chee E, Lipton RB,
et al. Epidemiology of constipation (EPOC) study in the United States:
relation of clinical subtypes to sociodemographic features. Am J
Gastroenterol 1999;94(12):3530-3540. [Medline] [CrossRef] |
| 16. |
Pare P,
Ferrazzi S, Thompson WG, Irvine EJ, Rance L. An epidemiological survey
of constipation in canada: definitions, rates, demographics, and
predictors of health care seeking. Am J Gastroenterol
2001;96(11):3130-3137. [Medline] [CrossRef] |
| 17. |
Drossman
DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE,
et al. U.S. householder survey of functional gastrointestinal disorders.
Prevalence, sociodemography, and health impact. Dig Dis Sci
1993;38(9):1569-1580. [Medline] [CrossRef] |
| 18. | Guo XF, Ke MY, Pan GZ. An epidemiologic and related factor analytical study of chronic constipation in Peking adult .A stratified randomized study by clustering sampling . Chinese Journal of Digestion. 2002;22(10):637-638. |
| 19. | Xong LS, Chen MH, Chen ZX, XU AG, Wang WA, Hu PJ. A community population-based epidemiologic study of chronic constipation in Guangdong province. Chinese Journal of Digestion. 2004; 24(8):488-491. |
| 20. | Liu SX, Zhang LZ, Yin SZ. Epidemiological investigation of Population Morbidity Rate of Constipation in the Urban Districts of Tianjin. Chinese Journal of Practical Surgery. 1994;14(9):533-535. |
| 21. |
Chan AO,
Cheng C, Hui WM, Hu WH, Wong NY, Lam KF, Wong WM, et al. Differing
coping mechanisms, stress level and anorectal physiology in patients
with functional constipation. World J Gastroenterol
2005;11(34):5362-5366. [Medline] |
| 22. |
Wald A,
Hinds JP, Caruana BJ. Psychological and physiological characteristics of
patients with severe idiopathic constipation. Gastroenterology
1989;97(4):932-937. [Medline] |
| 23. |
Mason HJ,
Serrano-Ikkos E, Kamm MA. Psychological morbidity in women with
idiopathic constipation. Am J Gastroenterol 2000;95(10):2852-2857. [Medline] [CrossRef] |
| 24. |
Nehra V,
Bruce BK, Rath-Harvey DM, Pemberton JH, Camilleri M. Psychological
disorders in patients with evacuation disorders and constipation in a
tertiary practice. Am J Gastroenterol 2000;95(7):1755-1758. [Medline] [CrossRef] |
| 25. |
Emmanuel
AV, Mason HJ, Kamm MA. Relationship between psychological state and
level of activity of extrinsic gut innervation in patients with a
functional gut disorder. Gut 2001;49(2):209-213. [Medline] [CrossRef] |
| 26. |
Dykes S,
Smilgin-Humphreys S, Bass C. Chronic idiopathic constipation: a
psychological enquiry. Eur J Gastroenterol Hepatol 2001;13(1):39-44. [Medline] [CrossRef] |
| 27. |
Beinfeld
MC, Korchak DM. The regional distribution and the chemical,
chromatographic, and immunologic characterization of motilin brain
peptides: the evidence for a difference between brain and intestinal
motilin-immunoreactive peptides. J Neurosci 1985;5(9):2502-2509. [Medline] |
| 28. | Chey WY, Escoffery FT, Roth F, Chang TM, Yajrma H. Motilin-like immunoreactivity (MLI) in the gut and neurons of peripheral and central nervous system. Regul Pept 1980: Suppl 7:519. |
| 29. | Hao Y, Xia GM, Zhou RS, Lou BX, Wang JC, Yang FJ, XuY, Ren J. Effects of sleep deprivation on gastric emptying and gastrointestinal hormone in rats. Chinese Journal of Clinical Rehabilitation. 2004;8(21):4236-4237. |
| 30. |
Phillis
JW, Kirkpatrick JR. The actions of motilin, luteinizing hormone
releasing hormone, cholecystokinin, somatostatin, vasoactive intestinal
peptide, and other peptides on rat cerebral cortical neurons. Can J
Physiol Pharmacol 1980;58(6):612-623. [Medline] |
| 31. | Zhou SQ, Song YH. The effect of motilin for the gastric motility. Modern Practical Medicine.2005;11(2):122-123. |
| 32. |
Allen JM,
Christofides ND, Cramer PA, Steinert J, Bloom SR. Elevated motilin
levels in patients treated with antidepressant and neuroleptic drugs. Br
J Psychiatry 1982;141(27-29. [Medline] |
| 33. | Li H, Li GC. Changes of Plasma MOT and Antroduodenal SP Expression in Rats with Functional Dyspepsia and Effect of Qingzhishu. Chinese Journal of Integrated Traditional and Western Medicine On Gastro-spleen.2003;11(1):12-15. |
| 34. | Pearse AGE, Polak JM, BloomL SR, Adams C, Dryburgh JR, Brown JC. Enterochromaffin cells of the mammalian small intestine as the source of motilin. Virchows Archiv B Cell Pathol. 1974;16(2):111-1120. |
| 35. |
Vantrappen G, Janssens J, Peeters TL, Bloom SR,
Christofides ND, Hellemans J. Motilin and the interdigestive migrating
motor complex in man. Dig Dis Sci 1979;24(7):497-500. [Medline] [CrossRef] |
| 36. |
Hellmich MR, Ives KL, Udupi V, Soloff MS, Greeley GH, Jr., Christensen
BN, Townsend CM, Jr. Multiple protein kinase pathways are involved in
gastrin-releasing peptide receptor-regulated secretion. J Biol Chem
1999;274(34):23901-23909. [Medline] [CrossRef] |
| 37. |
Simren M,
Bjornsson ES, Abrahamsson H. High interdigestive and postprandial
motilin levels in patients with the irritable bowel syndrome.
Neurogastroenterol Motil 2005;17(1):51-57. [Medline] [CrossRef] |
| 38. |
Preston
DM, Adrian TE, Christofides ND, Lennard-Jones JE, Bloom SR. Positive
correlation between symptoms and circulating motilin, pancreatic
polypeptide and gastrin concentrations in functional bowel disorders.
Gut 1985;26(10):1059-1064. [Medline] [CrossRef] |
| 39. |
Sirica
AE. Cholangiocarcinoma: molecular targeting strategies for
chemoprevention and therapy. Hepatology 2005;41(1):5-15. [Medline] [CrossRef] |
| 40. |
Sjolund
K, Ekman R, Lindgren S, Rehfeld JF. Disturbed motilin and
cholecystokinin release in the irritable bowel syndrome. Scand J
Gastroenterol 1996;31(11):1110-1114. [Medline] [CrossRef] |
| 41. |
Van Der
Veek PP, Biemond I, Masclee AA. Proximal and distal gut hormone
secretion in irritable bowel syndrome. Scand J Gastroenterol
2006;41(2):170-177. [Medline] [CrossRef] |
| 42. | Kuang RG, Kuang Y, Zhang Rl, Wang JW. Study on Relationship between Blood Motilin and Anorectal Function in Functional Outlet Obstructive Constipation. Journal of Chinese Physician.2005;7(7):871-873 |
Digital Object Identifier (DOI):10.4021/gr2010.02.168w
About
DOI and
CrossRef
Gastroenterology Research is a member of CrossRef.